Woodchuck hepatitis virus post-transcriptional regulatory element deleted from X protein and promoter sequences enhances retroviral vector titer and expression.
about
Progresses towards safe and efficient gene therapy vectorsImpact of age at administration, lysosomal storage, and transgene regulatory elements on AAV2/8-mediated rat liver transductionSelective inhibition of tumor growth by clonal NK cells expressing an ErbB2/HER2-specific chimeric antigen receptorDaedalus: a robust, turnkey platform for rapid production of decigram quantities of active recombinant proteins in human cell lines using novel lentiviral vectorsGeneration of healthy mice from gene-corrected disease-specific induced pluripotent stem cellsOviduct-specific expression of human neutrophil defensin 4 in lentivirally generated transgenic chickensA self-inactivating gamma-retroviral vector reduces manifestations of mucopolysaccharidosis I in miceLentiviral vector design and imaging approaches to visualize the early stages of cellular reprogramming.Development of a Wilms' tumor antigen-specific T-cell receptor for clinical trials: engineered patient's T cells can eliminate autologous leukemia blasts in NOD/SCID miceMucosal immunization with integrase-defective lentiviral vectors protects against influenza virus challenge in miceThe shedding of CD62L (L-selectin) regulates the acquisition of lytic activity in human tumor reactive T lymphocytes.Gammaretroviral vectors: biology, technology and applicationIn vitro generated anti-tumor T lymphocytes exhibit distinct subsets mimicking in vivo antigen-experienced cells.Construction of a novel expression cassette for increasing transgene expression in vivo in endothelial cells of large blood vessels.Identification of amino acid determinants in CYP4B1 for optimal catalytic processing of 4-ipomeanol.Foamy combinatorial anti-HIV vectors with MGMTP140K potently inhibit HIV-1 and SHIV replication and mediate selection in vivo.Increased functional protein expression using nucleotide sequence features enriched in highly expressed genes in zebrafish.Controlling AAV Tropism in the Nervous System with Natural and Engineered Capsids.Alpharetroviral self-inactivating vectors: long-term transgene expression in murine hematopoietic cells and low genotoxicity.Recombinant AAV Vectors for Enhanced Expression of Authentic IgG.Clinical-scale lentiviral vector transduction of PBL for TCR gene therapy and potential for expression in less-differentiated cells.Vector design for expression of O6-methylguanine-DNA methyltransferase in hematopoietic cells.Host Anti-antibody Responses Following Adeno-associated Virus-mediated Delivery of Antibodies Against HIV and SIV in Rhesus MonkeysTransferring a synthetic gene circuit from yeast to mammalian cells.Alpharetroviral vector-mediated gene therapy for X-CGD: functional correction and lack of aberrant splicing.Reducing the genotoxic potential of retroviral vectors.Live and let die: in vivo selection of gene-modified hematopoietic stem cells via MGMT-mediated chemoprotectionMyosin-II-mediated cell shape changes and cell intercalation contribute to primitive streak formation.Combinatorial incorporation of enhancer-blocking components of the chicken beta-globin 5'HS4 and human T-cell receptor alpha/delta BEAD-1 insulators in self-inactivating retroviral vectors reduces their genotoxic potential.Evaluating a ligation-mediated PCR and pyrosequencing method for the detection of clonal contribution in polyclonal retrovirally transduced samples.Enrichment of human hematopoietic stem/progenitor cells facilitates transduction for stem cell gene therapy.A simple and effective method to generate lentiviral vectors for ex vivo gene delivery to mature human peripheral blood lymphocytesLentiviral delivery of short hairpin RNAsOver-expression of secreted proteins from mammalian cell lines.Biosafety features of lentiviral vectorsNew developments in lentiviral vector design, production and purification.Lentiviral hematopoietic stem cell gene therapy in inherited metabolic disorders.Efficient generation of gene-modified human natural killer cells via alpharetroviral vectors.Evolving lessons on nanomaterial-coated viral vectors for local and systemic gene therapy.Improved retroviral episome transfer of transcription factors enables sustained cell fate modification.
P2860
Q26781432-E0AA5173-68C2-480F-9ADB-5DD8CFB86824Q27307010-2AF167AC-DE44-4515-95E4-435097CD1A08Q27318470-768DB387-4506-467F-918F-E1BB4F202B8DQ27673743-BE779638-2317-4E4D-9B80-A75B49CAD505Q28478987-D3441386-59F8-4C84-8F5B-4FE9E3898A16Q28547573-DEF746DF-FA6E-4111-8106-3C41DF483970Q30493690-96ABE831-4078-4410-9746-0CE17D963ABEQ30499307-2694B97E-514D-4871-A1DA-FB97077D7938Q33587590-8A050CB3-CEC9-448F-8827-65E57B02618AQ33604567-69B31297-198D-433B-8EDD-4DD034504F3DQ33987699-A71594D0-C530-4CC9-A31D-08AE8CB71DCEQ34223822-F2C24597-EDEB-4BC4-AC7E-D6C8ADE08953Q34827147-26BCD734-FFFF-462C-8C75-ABAA55B3A9E1Q34977697-1000C249-AEFD-4CE0-97AF-1C9790682B50Q35032512-1829DA5A-AC9A-48F7-B7A8-04BEBB9B308FQ35182775-C881DDAB-10F4-4AC2-B51B-4D144E3A1784Q35476197-68F117B3-B769-4E7B-99BE-061090C79967Q35853990-A4F97893-4049-47E6-9542-43496FFD5EDBQ35939492-4655970C-42A2-457C-A7BF-F8DE9D5FDA35Q36058890-C9F3F1DE-F6C7-4C12-A21D-94B5AAFA4642Q36102927-8F16BC60-23EA-48F3-A34B-AEDFC4DE180BQ36248825-28C31DDE-E4D7-4E1D-91C9-62EFF1E5DBAAQ36582838-A4384F5D-F4E4-4985-9DEC-A9D62833465BQ36614050-F1DD4932-1E31-4F41-A5CD-AA0181D9A313Q36659242-25353AAC-DAA0-41C9-88CC-AB52A123EC09Q36670724-A49917DD-9092-41E5-A337-CA9A6309E599Q36812597-E0121910-3E5D-4F3E-ABA5-234B4F4BB3E5Q36951037-B7D420DE-A07F-4383-B679-65010EC539B0Q37021156-4FA2DDE6-5FAF-4B08-9DA7-3FF067780816Q37066318-995AC8B8-AE5E-4065-8951-079DEDAC15C7Q37358032-3357FDE8-305A-416D-94D6-4ECE441F0D91Q37358371-0F0D9A84-B3B4-45F5-AE93-1B1373F6417EQ37430557-5568FB34-B247-4F8C-BF8E-5BFA4D9FD0CCQ37734441-8354A455-A4AB-4189-81EF-B9CA12341D5DQ38073294-AFECAD8C-6B8F-427D-9E54-A1D2BD6B2B7BQ38099382-DE618C53-8203-405A-8859-63229E5080FAQ38245751-D013B844-B7FD-404D-BF17-9CF37B8CEB73Q38841469-6AE06639-51F7-4C19-AC37-6D5118E816DAQ38848060-9FF5E334-EB11-4DB6-998D-9FBE75C3A8F0Q38968105-329C4324-215B-4BE9-9F4A-5511C10DD102
P2860
Woodchuck hepatitis virus post-transcriptional regulatory element deleted from X protein and promoter sequences enhances retroviral vector titer and expression.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Woodchuck hepatitis virus post ...... l vector titer and expression.
@en
type
label
Woodchuck hepatitis virus post ...... l vector titer and expression.
@en
prefLabel
Woodchuck hepatitis virus post ...... l vector titer and expression.
@en
P2093
P2860
P356
P1433
P1476
Woodchuck hepatitis virus post ...... l vector titer and expression.
@en
P2093
Giroglou T
Hermann FG
Schambach A
von Laer D
P2860
P2888
P304
P356
10.1038/SJ.GT.3302698
P577
2006-04-01T00:00:00Z
P5875
P6179
1048455565